Health copyright advised the Star it's contacted Adastra to “reiterate the very narrow parameters of their licence.” The business subsequently issued a 2nd launch Friday retracting what it explained in its initially statement and noting: “This kind of statements shouldn't be relied on.”“We will Appraise how the commercialization of the co